RISS 학술연구정보서비스

검색

인기 검색어

    다국어 입력

    http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

    변환된 중국어를 복사하여 사용하시면 됩니다.

    예시)
    • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
    • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
    닫기
    KCI등재 SCOPUS

    The Impact of Intrapericardial versus Intrapleural HeartMate 3 Pump Placement on Clinical Outcomes

    한글로보기

    https://www.riss.kr/link?id=A108147215

    • 0

      상세조회
    • 0

      다운로드
    서지정보 열기
    • 내보내기
    • 내책장담기
    • 공유하기
    • 오류접수

    부가정보

    다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

    Background: The integrated design of the HeartMate 3 (Abbott Laboratories, Chicago, IL, USA) affords flexibility to place the pump within the pericardium or thoracic cavity. We sought to determine whether the presence of a left ventricular assist device (LVAD) in either location has a meaningful impact on overall patient outcomes.
    Methods: A retrospective cohort study was conducted of all 165 patients who received a HeartMate 3 LVAD via a median sternotomy from November 2014 to August 2019 at our center. Based on operative reports and imaging, patients were divided into intrapleural (n=81) and intrapericardial (n=84) cohorts. The primary outcome of interest was in-hospital mortality, while secondary outcomes included postoperative complications, cumulative readmission incidence, and 3-year survival.
    Results: There were no significant between-group differences in baseline demographics, risk factors, or preoperative hemodynamics. The overall in-hospital mortality rate was 6%, with no significant difference between the cohorts (9% vs. 4%, p=0.20). There were no significant differences in the postoperative rates of right ventricular failure, kidney failure requiring hemodialysis, stroke, tracheostomy, or arrhythmias. Over 3 years, despite similar mortality rates, intrapleural patients had significantly more readmissions (n=180 vs. n=117, p<0.01) with the most common reason being infection (n=68/165), predominantly unrelated to the device. Intrapleural patients had significantly more infection-related readmissions, predominantly driven by non-ventricular assist device-related infections (p=0.02), with 41% of these due to respiratory infections compared with 28% of intrapericardial patients.
    Conclusion: Compared with intrapericardial placement, insertion of an intrapleural HM3 may be associated with a higher incidence of readmission, especially due to respiratory infection.
    번역하기

    Background: The integrated design of the HeartMate 3 (Abbott Laboratories, Chicago, IL, USA) affords flexibility to place the pump within the pericardium or thoracic cavity. We sought to determine whether the presence of a left ventricular assist devi...

    Background: The integrated design of the HeartMate 3 (Abbott Laboratories, Chicago, IL, USA) affords flexibility to place the pump within the pericardium or thoracic cavity. We sought to determine whether the presence of a left ventricular assist device (LVAD) in either location has a meaningful impact on overall patient outcomes.
    Methods: A retrospective cohort study was conducted of all 165 patients who received a HeartMate 3 LVAD via a median sternotomy from November 2014 to August 2019 at our center. Based on operative reports and imaging, patients were divided into intrapleural (n=81) and intrapericardial (n=84) cohorts. The primary outcome of interest was in-hospital mortality, while secondary outcomes included postoperative complications, cumulative readmission incidence, and 3-year survival.
    Results: There were no significant between-group differences in baseline demographics, risk factors, or preoperative hemodynamics. The overall in-hospital mortality rate was 6%, with no significant difference between the cohorts (9% vs. 4%, p=0.20). There were no significant differences in the postoperative rates of right ventricular failure, kidney failure requiring hemodialysis, stroke, tracheostomy, or arrhythmias. Over 3 years, despite similar mortality rates, intrapleural patients had significantly more readmissions (n=180 vs. n=117, p<0.01) with the most common reason being infection (n=68/165), predominantly unrelated to the device. Intrapleural patients had significantly more infection-related readmissions, predominantly driven by non-ventricular assist device-related infections (p=0.02), with 41% of these due to respiratory infections compared with 28% of intrapericardial patients.
    Conclusion: Compared with intrapericardial placement, insertion of an intrapleural HM3 may be associated with a higher incidence of readmission, especially due to respiratory infection.

    더보기

    참고문헌 (Reference)

    1 Lanfear AT, "Trends in HeartMate 3 : what we know so far" 35 : 180-187, 2020

    2 Taghavi S, "Surgical technique influences HeartMate II left ventricular assist device thrombosis" 96 : 1259-1265, 2013

    3 Shih H, "Serial assessment of HeartMate 3pump position and inflow angle and effects on adverse events" 59 : 1166-1173, 2021

    4 Kilic A, "Pump position impacts Heart-Mate II left ventricular assist device thrombosis" 65 : 227-232, 2019

    5 Kang G, "Pulmonary artery pulsatility index predicts right ventricular failure after left ventricular assist device implantation" 35 : 67-73, 2016

    6 Adamson RM, "Principles of HeartMate II implantation to avoid pump malposition and migration" 30 : 296-299, 2015

    7 Imamura T, "Optimal cannula positioning of HeartMate 3 left ventricular assist device" 44 : e509-19, 2020

    8 Wachter K, "Minimally invasive versus conventional LVAD-implantation : an analysis of the literature" 67 : 156-163, 2019

    9 Kazui T, "Left ventricular assist device inflow angle and pump positional change over time adverse impact on left ventricular assist device function" 102 : 1933-1940, 2016

    10 Kaku Y, "Late inflow or outflow obstruction requiring surgical intervention after HeartMate 3 left ventricular assist device insertion" 31 : 626-628, 2020

    1 Lanfear AT, "Trends in HeartMate 3 : what we know so far" 35 : 180-187, 2020

    2 Taghavi S, "Surgical technique influences HeartMate II left ventricular assist device thrombosis" 96 : 1259-1265, 2013

    3 Shih H, "Serial assessment of HeartMate 3pump position and inflow angle and effects on adverse events" 59 : 1166-1173, 2021

    4 Kilic A, "Pump position impacts Heart-Mate II left ventricular assist device thrombosis" 65 : 227-232, 2019

    5 Kang G, "Pulmonary artery pulsatility index predicts right ventricular failure after left ventricular assist device implantation" 35 : 67-73, 2016

    6 Adamson RM, "Principles of HeartMate II implantation to avoid pump malposition and migration" 30 : 296-299, 2015

    7 Imamura T, "Optimal cannula positioning of HeartMate 3 left ventricular assist device" 44 : e509-19, 2020

    8 Wachter K, "Minimally invasive versus conventional LVAD-implantation : an analysis of the literature" 67 : 156-163, 2019

    9 Kazui T, "Left ventricular assist device inflow angle and pump positional change over time adverse impact on left ventricular assist device function" 102 : 1933-1940, 2016

    10 Kaku Y, "Late inflow or outflow obstruction requiring surgical intervention after HeartMate 3 left ventricular assist device insertion" 31 : 626-628, 2020

    11 Gosev I, "Implantation of a fully magnetically levitated left ventricular assist device using a sternal-sparing surgical technique" 39 : 37-44, 2020

    12 Schmitto JD, "Implantation of a centrifugal pump as a left ventricular assist device through a novel, minimized approach: upper hemisternotomy combined with anterolateral thoracotomy" 143 : 511-513, 2012

    13 Organ Procurement and Transplantation Network, "Criteria requirements in adult heart allocation policy" Organ Procurement and Transplantation Network

    14 LaRue SJ, "Clinical outcomes associated with INTERMACS-defined right heart failure after left ventricular assist device implantation" 36 : 475-477, 2017

    15 Carrozzini M, "Bilateral mini-thoracotomy approach for minimally invasive implantation of HeartMate 3" 43 : 593-595, 2019

    16 Imamura T, "Association of inflow cannula position with left ventricular unloading and clinical outcomes in patients with HeartMate II left ventricular assist device" 65 : 331-335, 2019

    17 Boyd WD, "A review of the current status of pericardial closure following cardiac surgery" 10 : 1109-1118, 2012

    더보기

    동일학술지(권/호) 다른 논문

    분석정보

    View

    상세정보조회

    0

    Usage

    원문다운로드

    0

    대출신청

    0

    복사신청

    0

    EDDS신청

    0

    동일 주제 내 활용도 TOP

    더보기

    주제

    연도별 연구동향

    연도별 활용동향

    연관논문

    연구자 네트워크맵

    공동연구자 (7)

    유사연구자 (20) 활용도상위20명

    인용정보 인용지수 설명보기

    학술지 이력

    학술지 이력
    연월일 이력구분 이력상세 등재구분
    2023 평가 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
    2021-01-01 학술지명변경 한글명 : The Korean Journal of Thoracic and Cardiovascular Surgery -> Journal of Chest Surgery
    외국어명 : The Korean Journal of Thoracic and Cardiovascular Surgery -> Journal of Chest Surgery
    KCI등재
    2020-01-01 등재 등재학술지 유지 (해외등재 학술지 평가) KCI등재
    2011-07-08 학술지명변경 한글명 : 대한흉부외과학회지 -> The Korean Journal of Thoracic and Cardiovascular Surgery KCI등재
    2011-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2009-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2007-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2004-01-01 등재 등재학술지 선정 (등재후보2차) KCI등재
    2003-01-01 등재 등재후보 1차 PASS (등재후보1차) KCI등재후보
    2002-01-01 등재 등재후보학술지 유지 (등재후보1차) KCI등재후보
    1999-07-01 등재 등재후보학술지 선정 (신규평가) KCI등재후보
    더보기

    학술지 인용정보

    학술지 인용정보
    기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
    2016 0.03 0.03 0.05
    KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
    0.06 0.05 0.165 0.01
    더보기

    이 자료와 함께 이용한 RISS 자료

    나만을 위한 추천자료

    해외이동버튼